½ÃÀ庸°í¼­
»óǰÄÚµå
1705708

¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Global Pediatric Perfusion Market, By Product Type, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀåÀº 2025³â 5¾ï 7,530¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â±îÁö 8¾ï 4,250¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö CAGR 5.6%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 5¾ï 7,530¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR: 5.60% 2032³â °¡Ä¡ ¿¹Ãø 8¾ï 4,250¸¸ ´Þ·¯
±×¸². ¼Ò¾Æ¿ë °ü·ù ¼¼°è ½ÃÀå Á¡À¯À²(%), 2025³â Áö¿ªº°
Global Pediatric Perfusion Market-IMG1

¼Ò¾Æ¿ë °ü·ù´Â °³½É¼ú Áß ½ÉÆó ¿ìȸ(CPB)¸¦ ¹Þ´Â ¼Ò¾ÆÀÇ ¼øÈ¯°è¸¦ ÅëÇØ Ç÷¾×À» º¸³»´Â °ÍÀÔ´Ï´Ù. ¼Ò¾Æ ȯÀÚÀÇ ÇØºÎÇÐÀû, »ý¸®ÇÐÀû Â÷ÀÌ¿¡ ´ëÀÀÇϱâ À§ÇÑ Æ¯¼öÇÑ ÀåÄ¡, ±â¼ú, ±â´ÉÀÌ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°èº¸°Ç±â±¸(WHO)ÀÇ Ãß°è¿¡ ÀÇÇϸé, ¼±Ãµ¼º ½ÉÁúȯ(CHD)Àº Ãâ»ý¾ÆÀÇ °ÅÀÇ 1%¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁúȯÀÔ´Ï´Ù. Áø´Ü±â¼úÀÇ Çâ»ó¿¡ ÀÇÇØ CHDÀÇ Á¶±â ¹ß°ßÀÌ °¡´ÉÇØÁ® ¾Æµ¿ ½ÉÀå ¿Ü°ú ¼ö¼úÀÇ Áøº¸¿Í ÇÔ²² »ýÁ¸À²°ú Ä¡·á ¼ºÀûÀÌ Çâ»óµÇ¾ú½À´Ï´Ù.

¼Ò¾Æ¿ë °ü·ù´Â Àΰø ½ÉÆó ÀåÄ¡¸¦ »ç¿ëÇÏ¿© ½ÉÀå ¼ö¼ú Áß ¼Ò¾ÆÀÇ ½ÉÆó ±â´ÉÀ» Áö¿øÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó Ư¼öÇÑ °ü·ùÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

±×·¯³ª ¼Ò¾Æ¿ë °ü·ù ½ÃÀåÀº °úÁ¦¿¡µµ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¼Ò¾Æ ½ÉÀå ¼ö¼úÀÇ °í°¡ÀÇ ºñ¿ëÀº ƯÈ÷ Á¾ÇÕÀûÀÎ ÀÇ·á º¸ÇèÀÌ Àû¿ëµÇÁö ¾Ê´Â Áö¿ª¿¡¼­´Â ÇコÄÉ¾î ½Ã½ºÅÛ°ú °¡Á·¿¡°Ô Å« °æÁ¦Àû ºÎ´ãÀÌ µÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¼Ò¾Æ¿ë °ü·ù Àü¹®ÀÇÀÇ ºÎÁ·ÀÌ ÁöÀûµÇ°í ÀÖ½À´Ï´Ù. ´Ù¸¥ °úÁ¦´Â °ü·ù ÀåÄ¡ ½ÃÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ´Â ¿ÀÇÁ ÆßÇÁ ¿Ü°ú ¼ö¼ú¿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁö°í ÀÖ´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼úÀº ½ÉÀåÀ» ¸ØÃßÁö ¾Ê°í ÇàÇØÁö±â ¶§¹®¿¡ Àΰø ½ÉÆó ÀåÄ¡¸¦ ÇÊ¿ä·Î ÇÏÁö ¾Ê°í, °ü·ù ¼­ºñ½º ¼ö¿ä°¡ °¨¼ÒÇÕ´Ï´Ù.

ÀÌ·¯ÇÑ °úÁ¦¿¡µµ ºÒ±¸ÇÏ°í ¼Ò¾Æ¿ë °ü·ù ½ÃÀåÀº ƯÈ÷ ¼ÒÇüÈ­µÈ °ü·ù ÀåÄ¡ÀÇ ±â¼ú Çõ½Å°ú °³¹ß¿¡ Å« ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. ½ÃÀåÀÇ ±â¾÷¿¡°Ô ¸Å·ÂÀûÀÎ ±âȸ¸¦ Á¦°øÇÏ´Â °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ÇコÄɾîÀÇ ÀÎÇÁ¶ó°¡ È®´ëµÇ¾î, ¼Ò¾Æ ½ÉÀå ÀÇ·á¿¡ÀÇ ¾×¼¼½º°¡ °³¼±µÇ°í ÀÖ´Â ½ÅÈï ½ÃÀå¿¡µµ ¼ºÀåÀÇ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

¿ä¾à: ÀÇ·á Áøº¸°¡ °è¼ÓµÇ´Â °¡¿îµ¥, ¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀåÀº ºñ¿ë, Æ®·¹ÀÌ´×, ±â¼ú¿¡ °üÇÑ °úÁ¦¿¡ Àü·«ÀûÀ¸·Î ´ëóÇÒ ¼ö ÀÖÀ¸¸é, ¼ºÀåÇÏ´Â ÁÁÀº À§Ä¡¿¡ ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â, 2024³âÀ» ±âÁØ¿¬µµ·Î) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
  • ¶Ç, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ¼ºÀå ±âȸ¸¦ ¹àÇô, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¿¡ ´ëÇØ¼­ ÇØ¼³Çß½À´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã³ª ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±Ù°ÅÇØ, ¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀå¿¡ À־ÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­·ÎºÎÅÍÀÇ ÀλçÀÌÆ®´Â ¸¶ÄÉÆÃ ´ã´çÀÚ³ª ±â¾÷ÀÇ °æ¿µÁøÀÌ, Àå·¡ÀÇ Á¦Ç° ¹ß¸Å, À¯Çü ¾÷, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç °áÁ¤À» ½Ç½ÃÇÏ´Â °ÍÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.
  • ¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±ÞÀÚ, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ¾Ö³Î¸®½ºÆ® µî, ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´ë»óÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀåÀÇ ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ, ÀÇ»ç °áÁ¤ÀÌ ¿ëÀÌÇÏ°Ô µË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã/½ÂÀÎ
  • PEST ºÐ¼®
  • PORTER ºÐ¼®
  • ÇÕº´°ú Àμö ½Ã³ª¸®¿À

Á¦4Àå ¼¼°è ¼Ò¾Æ¿ë °ü·ù ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃøÀÇ ºÐ¼®
  • °æÁ¦¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

  • ¼Ò¾Æ¿ë ij´¼¶ó
  • ¿ø½É Ç÷¾× ÆßÇÁ
  • ¼Ò¾Æ µ¿¸Æ¶óÀÎ
  • ¸·Çü ÀΰøÆó
  • ü¿Ü ¼øÈ¯ ȸ·Î
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀå, ¿ëµµº°, 2020-2032³â

  • ½ÉÀåÇ÷°ü ¼ö¼ú
  • È£Èí±â°è ¿ëµµ
  • ü¿Ü¸·Çü ÀΰøÆó
  • ½ÉÆó ¿ìȸ
  • Àå±â °ü·ù¿Í º¸Á¸
  • Àå±â À̽Ä
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°, 2020-2032³â

  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¼Ò¾Æ¿ë °ü·ù ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • Medtronic
  • GE Healthcare
  • LivaNova, PLC.
  • Getinge
  • Braile Biomedica
  • XENIOS AG
  • BL Lifesciences
  • Terumo Corporation
  • 3M
  • Koninklijke Philips NV
  • EUROSETS
  • Merck KGaA
  • Stryker
  • Cardinal Health
  • Nonin
  • Sorin Group USA, Inc.

Á¦10Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
JHS 25.05.19

Global Pediatric Perfusion Market is estimated to be valued at USD 575.3 Mn in 2025 and is expected to reach USD 842.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 575.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.60% 2032 Value Projection: USD 842.5 Mn
Figure. Global Pediatric Perfusion Market Share (%), By Region 2025
Global Pediatric Perfusion Market - IMG1

Pediatric perfusion is the delivery of blood through the circulatory system in children undergoing cardiopulmonary bypass (CPB) during open heart surgery. CPB involves diverting the patient's blood circulation through a heart-lung machine to maintain circulation and lung gas exchange while the heart is stopped during specific parts of the surgical repair. Pediatric perfusion requires specialized equipment, techniques, and skills to handle the anatomical and physiological differences between adult and pediatric patients. Over the past few decades, procedural success rates have significantly improved due to advancements in perfusion technologies, circuit design modifications, and innovations in surgical techniques tailored for children. However, congenital heart defects continue to be one of the major causes of infant mortality worldwide.

Market Dynamics:

The global pediatric perfusion market is experiencing growth primarily due to the increasing incidence of congenital heart diseases (CHD), a condition affecting nearly 1% of live births according to World Helath Organization (WHO) estimates. Improved diagnostic techniques have led to the early identification of CHD, which, coupled with advancements in pediatric cardiac surgical procedures, has improved survival rates and outcomes. Consequently, this has elevated the number of children who can benefit from pediatric cardiac surgeries and, by extension, pediatric perfusion services.

Pediatric perfusion involves the use of a heart-lung machine to support the child's cardiopulmonary functions during cardiac surgery. As more newborns and infants are diagnosed with CHD and undergo corrective or palliative surgeries, the demand for specialized perfusion equipment has grown. The surgical advancements have allowed for complex cardiac interventions to be performed at earlier stages of life, extending the longevity and quality of life of pediatric CHD patients.

However, the pediatric perfusion market does face challenges. The high cost of pediatric cardiac surgeries can be a significant financial burden for healthcare systems and families, particularly in regions without comprehensive health insurance coverage. Moreover, pediatric perfusion requires specific expertise, and there is a recognized gap in the availability of trained pediatric perfusionists. Another challenge is the increasing focus on off-pump surgical procedures, which can limit the market for perfusion equipment. These surgeries, performed without stopping the heart, may not require a heart-lung machine, thereby decreasing the demand for perfusion services.

Despite these challenges, there are substantial opportunities in the pediatric perfusion market, particularly in the innovation and development of miniaturized perfusion equipment. These devices are better suited for the physiological needs of neonates and infants, offering more precise control and reduced complications. This represents a significant advancement in pediatric cardiac care, offering an attractive opportunity for players in the market. There is also potential for growth in emerging markets, where healthcare infrastructure is expanding, and access to pediatric cardiac care is improving. The burgeoning demand for healthcare services in these regions can stimulate market expansion.

In summary, as medical advancements continue, the global pediatric perfusion market is well-positioned for growth, provided that challenges around costs, training, and technology are strategically addressed. Manufacturers and healthcare providers can capitalize on these opportunities by investing in specialized, cost-effective, and technologically advanced perfusion systems designed for pediatric care.

Key Features of the Study:

  • This report provides an in-depth analysis of the global pediatric perfusion market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pediatric perfusion market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic, GE Healthcare, LivaNova, PLC., Getinge, Braile Biomedica, XENIOS AG, BL Lifesciences, Terumo Corporation, 3M, Koninklijke Philips N.V., EUROSETS, Merck KGaA, Stryker, Cardinal Health, Nonin, and Sorin Group USA, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pediatric perfusion market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric perfusion market

Detailed Segmentation:

  • By Product Type:
    • Pediatric Cannulas
    • Centrifugal Blood Pumps
    • Pediatric Arterial Lines
    • Membrane Oxygenators
    • Extracorporeal Circuits
    • Others
  • By Application
    • Cardiovascular Surgery
    • Respiratory Applications
    • Extracorporeal Membrane Oxygenation
    • Cardiopulmonary Bypass
    • Organ Perfusion and Preservation
    • Organ Transplantation
    • Others
  • By End User
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Medtronic
    • GE Healthcare
    • LivaNova, PLC.
    • Getinge
    • Braile Biomedica
    • XENIOS AG
    • BL Lifesciences
    • Terumo Corporation
    • 3M
    • Koninklijke Philips N.V.
    • EUROSETS
    • Merck KGaA
    • Stryker
    • Cardinal Health
    • Nonin
    • Sorin Group USA, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Pediatric Perfusion Market, By Product Type
    • Pediatric Perfusion Market, By Application
    • Pediatric Perfusion Market, By End User
    • Pediatric Perfusion Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • The increasing incidence of cardiovascular diseases (CVDs) in the pediatric population
    • Increasing government initiatives and funding
    • The emergence of new technologies in pediatric perfusion
    • Technological advancements
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Pediatric Perfusion Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Pediatric Perfusion Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pediatric Cannulas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Centrifugal Blood Pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Pediatric Arterial Lines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Membrane Oxygenators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Extracorporeal Circuits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Pediatric Perfusion Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Cardiovascular Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Respiratory Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Extracorporeal Membrane Oxygenation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cardiopulmonary Bypass
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Organ Perfusion and Preservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Organ Transplantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Pediatric Perfusion Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Pediatric Perfusion Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Medtronic
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LivaNova, PLC.
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Getinge
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braile Biomedica
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • XENIOS AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BL Lifesciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • 3M
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • EUROSETS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Stryker
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cardinal Health
  • Nonin
  • Sorin Group USA, Inc.
  • Analyst Views

10. Section

  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦